time length phase iii, page-20

that said, Martin Rogers rold me by phone a couple of weeks ago whilst the rest of world market (i.e. not US) is equal to US, getting US is their primary focus (apart from ANZ) because that way the rest of world sits up and takes positive notice. He mentioned that Singapore for example have high standards but do not have an approval path for such drugs; they would rely on and wait for FDA.

the good thing is that when FDA do approve, it will be like a nuke going off for Prima as all markets will be more or less open based solely on that.

planet